Literature DB >> 17192316

Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx.

Daniel F Gaddy1, Douglas S Lyles.   

Abstract

Matrix (M) protein mutants of vesicular stomatitis virus (VSV) are promising oncolytic agents for cancer therapy. Previous research has implicated Fas and PKR in apoptosis induced by other viruses. Here, we show that dominant-negative mutants of Fas and PKR inhibit M protein mutant virus-induced apoptosis. Most previous research has focused on the adapter protein FADD as a necessary transducer of Fas-mediated apoptosis. However, the expression of dominant-negative FADD had little effect on the induction of apoptosis by M protein mutant VSV. Instead, virus-induced apoptosis was inhibited by the expression of a dominant-negative mutant of the adapter protein Daxx. These data indicate that Daxx is more important than FADD for apoptosis induced by M protein mutant VSV. These results show that PKR- and Fas-mediated signaling play important roles in cell death during M protein mutant VSV infection and that Daxx has novel functions in the host response to virus infection by mediating virus-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192316      PMCID: PMC1865982          DOI: 10.1128/JVI.01760-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression.

Authors:  O Donzé; J Dostie; N Sonenberg
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

2.  Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway.

Authors:  S Balachandran; P C Roberts; T Kipperman; K N Bhalla; R W Compans; D R Archer; G N Barber
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).

Authors:  S Torii; D A Egan; R A Evans; J C Reed
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

4.  Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.

Authors:  H Li; C Leo; J Zhu; X Wu; J O'Neil; E J Park; J D Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression.

Authors:  Sarah A Kopecky; Douglas S Lyles
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.

Authors:  Oliver Ebert; Katsunori Shinozaki; Tian-Gui Huang; Mikko J Savontaus; Adolfo García-Sastre; Savio L C Woo
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

7.  Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling.

Authors:  S Balachandran; C N Kim; W C Yeh; T W Mak; K Bhalla; G N Barber
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

8.  Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.

Authors:  Masatsugu Obuchi; Marilyn Fernandez; Glen N Barber
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 9.  Reovirus-induced apoptosis: A minireview.

Authors:  P Clarke; K L Tyler
Journal:  Apoptosis       Date:  2003-03       Impact factor: 4.677

10.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx.

Authors:  H Y Chang; H Nishitoh; X Yang; H Ichijo; D Baltimore
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

View more
  36 in total

1.  Chandipura virus induces neuronal death through Fas-mediated extrinsic apoptotic pathway.

Authors:  Sourish Ghosh; Kallol Dutta; Anirban Basu
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix protein.

Authors:  Dequan Zeng; Tao Zhang; Shengtao Zhou; Hao Hu; Jingyi Li; Kai Huang; Yunlong Lei; Kui Wang; Yong Zhao; Rui Liu; Qiu Li; Yanjun Wen; Canhua Huang
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

Review 3.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

4.  Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.

Authors:  Cassandra L Braxton; Shelby H Puckett; Steven B Mizel; Douglas S Lyles
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

5.  Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.

Authors:  Byram W Bridle; Jeanette E Boudreau; Brian D Lichty; Jérôme Brunellière; Kyle Stephenson; Sandeep Koshy; Jonathan L Bramson; Yonghong Wan
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

6.  Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Authors:  Megan Moerdyk-Schauwecker; Nirav R Shah; Andrea M Murphy; Eric Hastie; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  Virology       Date:  2012-12-14       Impact factor: 3.616

7.  Apoptosis induction in BEFV-infected Vero and MDBK cells through Src-dependent JNK activation regulates caspase-3 and mitochondria pathways.

Authors:  Chun-Yen Chen; Chin-Yang Chang; Hung-Jen Liu; Ming-Huei Liao; Chi-I Chang; Jue-Liang Hsu; Wen-Ling Shih
Journal:  Vet Res       Date:  2009-10-23       Impact factor: 3.683

8.  Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.

Authors:  Jason R Smedberg; Marlena M Westcott; Maryam Ahmed; Douglas S Lyles
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis.

Authors:  Sara Samuel; Vladimir Beljanski; Julien Van Grevenynghe; Stephanie Richards; Fethia Ben Yebdri; Zhong He; Carmen Nichols; S Mehdi Belgnaoui; Courtney Steel; Marie-Line Goulet; April Shamy; Dawn Brown; Guillermo Abesada; Elias K Haddad; John Hiscott
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

10.  Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.

Authors:  Vanessa Fonseca Tumilasci; Stephanie Olière; Thi Lien-Ahn Nguyên; April Shamy; John Bell; John Hiscott
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.